Search research articles
Contact Us
Filters
Showing results (931-940 of 969) with videos related to
Page
of 97
Sort By:
ACS Medicinal Chemistry Letters
|
October 24, 2017
Stabilizing a Tubulysin Antibody-Drug Conjugate To Enable Activity Against Multidrug-Resistant Tumors
Leanna R Staben, Shang-Fan Yu, Jinhua Chen, et al.
Molecular Cancer Therapeutics
|
March 16, 2021
Calicheamicin Antibody-Drug Conjugates with Improved Properties
Breanna S Vollmar, Chris Frantz, Melissa M Schutten, et al.
Nutrition Journal
|
October 24, 2025
Feasibility of using Simple Diet Self-Assessment Tool (SDSAT) to explore patterns of dietary intake for patients undergoing chemotherapy
Wen-Jie Zhu, Min Yang, Bao-Hua Zou, et al.
Nature Chemistry
|
November 23, 2016
Targeted drug delivery through the traceless release of tertiary and heteroaryl amines from antibody-drug conjugates
Leanna R Staben, Stefan G Koenig, Sophie M Lehar, et al.
Molecular Psychiatry
|
April 14, 2026
What are the correlates of non-suicidal self-injury in children and adolescents? An umbrella systematic review of global evidence
Yi Zhong, Zi-Wei Zhang, Jia-Hao Ding, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease
|
August 15, 2025
An Ile to Met polymorphism in ADCY9 promotes airway obstruction and remodeling in asthma
Li-Mei Liang, Peng-Cheng Cai, Fan Yu, et al.
Bioconjugate Chemistry
|
February 27, 2018
Modulating Antibody-Drug Conjugate Payload Metabolism by Conjugation Site and Linker Modification
Dian Su, Katherine R Kozak, Jack Sadowsky, et al.
Nature Chemical Biology
|
February 22, 2023
Publisher Correction: Small molecule agonist of mitochondrial fusion repairs mitochondrial dysfunction
Yingjie Guo, Huan Zhang, Chen Yan, et al.
Nature Chemical Biology
|
January 12, 2023
Small molecule agonist of mitochondrial fusion repairs mitochondrial dysfunction
Yingjie Guo, Huan Zhang, Chen Yan, et al.
Molecular Cancer Therapeutics
|
April 20, 2013
DCDT2980S, an anti-CD22-monomethyl auristatin E antibody-drug conjugate, is a potential treatment for non-Hodgkin lymphoma
Dongwei Li, Kirsten Achilles Poon, Shang-Fan Yu, et al.
Page
of 97
Search research articles
Search
Showing results (931-940 of 969) with videos related to
Sort By:
Page
of 97
ACS Medicinal Chemistry Letters
|
October 24, 2017
Stabilizing a Tubulysin Antibody-Drug Conjugate To Enable Activity Against Multidrug-Resistant Tumors
Leanna R Staben, Shang-Fan Yu, Jinhua Chen, et al.
Molecular Cancer Therapeutics
|
March 16, 2021
Calicheamicin Antibody-Drug Conjugates with Improved Properties
Breanna S Vollmar, Chris Frantz, Melissa M Schutten, et al.
Nutrition Journal
|
October 24, 2025
Feasibility of using Simple Diet Self-Assessment Tool (SDSAT) to explore patterns of dietary intake for patients undergoing chemotherapy
Wen-Jie Zhu, Min Yang, Bao-Hua Zou, et al.
Nature Chemistry
|
November 23, 2016
Targeted drug delivery through the traceless release of tertiary and heteroaryl amines from antibody-drug conjugates
Leanna R Staben, Stefan G Koenig, Sophie M Lehar, et al.
Molecular Psychiatry
|
April 14, 2026
What are the correlates of non-suicidal self-injury in children and adolescents? An umbrella systematic review of global evidence
Yi Zhong, Zi-Wei Zhang, Jia-Hao Ding, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease
|
August 15, 2025
An Ile to Met polymorphism in ADCY9 promotes airway obstruction and remodeling in asthma
Li-Mei Liang, Peng-Cheng Cai, Fan Yu, et al.
Bioconjugate Chemistry
|
February 27, 2018
Modulating Antibody-Drug Conjugate Payload Metabolism by Conjugation Site and Linker Modification
Dian Su, Katherine R Kozak, Jack Sadowsky, et al.
Nature Chemical Biology
|
February 22, 2023
Publisher Correction: Small molecule agonist of mitochondrial fusion repairs mitochondrial dysfunction
Yingjie Guo, Huan Zhang, Chen Yan, et al.
Nature Chemical Biology
|
January 12, 2023
Small molecule agonist of mitochondrial fusion repairs mitochondrial dysfunction
Yingjie Guo, Huan Zhang, Chen Yan, et al.
Molecular Cancer Therapeutics
|
April 20, 2013
DCDT2980S, an anti-CD22-monomethyl auristatin E antibody-drug conjugate, is a potential treatment for non-Hodgkin lymphoma
Dongwei Li, Kirsten Achilles Poon, Shang-Fan Yu, et al.
Page
of 97